Verrica Pharmaceuticals Inc.
VRCA
$6.73
-$0.82-10.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -274.00K | 204.00K | -9.74M | -16.20M | -22.86M |
| Total Depreciation and Amortization | 184.00K | 199.00K | 208.00K | 253.00K | 342.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.84M | 1.16M | 1.44M | 3.98M | 2.94M |
| Change in Net Operating Assets | 7.93M | -11.61M | -4.59M | -4.09M | 11.02M |
| Cash from Operations | 9.69M | -10.04M | -12.68M | -16.06M | -8.56M |
| Capital Expenditure | -- | -- | -- | 0.00 | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 8.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 8.00K | -16.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.98M | -4.16M | -4.06M | -374.00K | -217.00K |
| Issuance of Common Stock | -- | -- | -- | 39.64M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 162.00K | -180.00K |
| Cash from Financing | -3.98M | -4.16M | -4.06M | 39.43M | -397.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.70M | -14.20M | -16.73M | 23.37M | -8.97M |